Long-Term Debt: The sum of all long term debt fields.
Anavex Life Sciences Corp. (AVXL) Long-Term Debt data is not available for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-8.62M |
|
-- |
|
-- |
|
$11.29M |
|
$-11.29M |
|
$2.76M |
|
$-8.54M |
|
$-8.54M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-11.29M |
|
$-11.29M |
|
82.08M |
|
82.08M |
|
$-0.11 |
|
$-0.11 |
|
Balance Sheet Financials | |
$148.07M |
|
-- |
|
-- |
|
$148.07M |
|
$12.49M |
|
Long-Term Debt |
-- |
-- |
|
$12.49M |
|
$135.57M |
|
$135.57M |
|
$135.57M |
|
82.09M |
|
Cash Flow Statement Financials | |
$-7.32M |
|
-- |
|
$0.06M |
|
$151.02M |
|
$143.76M |
|
$-7.26M |
|
$2.29M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
11.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.36% |
|
-6.36% |
|
-5.82% |
|
-6.36% |
|
$1.65 |
|
$-0.09 |
|
$-0.09 |